Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Lacosamide is indicated to treat partial-onset seizures
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Digital success is contingent on the way a company organizes itself around technology
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
To create leading company developing medicines targeting metalloenzymes
Subscribe To Our Newsletter & Stay Updated
